Morgan Stanley Downgrades Globus Medical (GMED) to Equalweight
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $83.94 --0%
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 18 | New: 12
Rating Summary:
22 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 18 | New: 12
Join SI Premium – FREE
Morgan Stanley downgraded Globus Medical (NYSE: GMED) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $26.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Fox Factory Holding (FOXF) to Underperform
- Oppenheimer Downgrades Bank of America (BAC) to Perform
- Arete Downgrades The Trade Desk (TTD) to Sell
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
